eladocagene exuparvovec sold brand name upstaza gene therapy product treatment aromatic acid decarboxylase aadc infuses gene encoding human aadc enzyme putamen region subsequent expression aadc results dopamine production result development motor function patients aadc common side effects include initial insomnia irritability eladocagene exuparvovec approved medical use european union july eladocagene exuparvovec indicated treatment aromatic lamino acid decarboxylase aadc eladocagene exuparvovec international nonproprietary name may committee medicinal products human use chmp european medicines agency ema adopted positive opinion recommending granting marketing authorization exceptional circumstances medicinal product upstaza intended treatment aromatic acid decarboxylase aadc upstaza advanced therapy medicinal product chmp positive opinion based assessment committee advanced applicant medicinal product ptc therapeutics international eladocagene exuparvovec approved medical use european union july pharmacologyrelated article stub help wikipedia expanding ithttpsenwikipediaorgwikieladocageneexuparvovec